Intravitreal bevacizumab for the treatment of retinopathy of prematurity: a case report.

Objective: We report the first case in Scotland of a premature infant treated for retinopathy of prematurity with bevacizumab.

Method: A case report and a review of the literature are presented.

Results: Retinopathy of prematurity is a leading worldwide cause of childhood blindness.